Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial
Titel:
Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial
Auteur:
Trillsch, F. Mahner, S. Hilpert, F. Davies, L. García-Martínez, E. Kristensen, G. Savarese, A. Vuylsteke, P. Los, M. Zagouri, F. Gladieff, L. Sehouli, J. Khoon Lee, C. Gebski, V. Pujade-Lauraine, E.